OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $310,000 Invested

2022

FINGERS Brain Health Institute

Miia Kivipelto, MD, PhD

Blood-based biomarkers of Alzheimer’s disease and neurodegeneration in the FINGER multidomain trial

  • Funding Amount: $310,000
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Target: Neuronal Degeneration
  • Status: Active